Trials / Unknown
UnknownNCT03648788
A Post-marketing Surveillance to Assess Safety and Efficacy of Rosuvatatin/Ezetimibe
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Post-marketing surveillance of Rosuvastatin/Ezetimibe
Detailed description
This study will collect clinical data, mainly focused on safety, in Korean population as per the requirement of MFDS for market authorization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | NA (Observation study) | NA (Observation study) |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2024-06-01
- Completion
- 2024-08-01
- First posted
- 2018-08-27
- Last updated
- 2018-09-06
Source: ClinicalTrials.gov record NCT03648788. Inclusion in this directory is not an endorsement.